Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

J Am Acad Child Adolesc Psychiatry. 2015 Jul;54(7):532-4. doi: 10.1016/j.jaac.2015.04.003.
No abstract available

Publication types

  • Review

MeSH terms

  • Atomoxetine Hydrochloride / administration & dosage*
  • Atomoxetine Hydrochloride / pharmacokinetics
  • Cytochrome P-450 CYP2D6 / genetics
  • Cytochrome P-450 CYP2D6 / metabolism*
  • Humans
  • Pharmacogenetics*
  • Practice Guidelines as Topic
  • Precision Medicine
  • Randomized Controlled Trials as Topic
  • United States
  • United States Food and Drug Administration

Substances

  • Atomoxetine Hydrochloride
  • Cytochrome P-450 CYP2D6